ClinicalTrials.Veeva

Menu

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Stanford University logo

Stanford University

Status

Enrolling

Conditions

Hodgkin's Disease
Lymphoma, Non-Hodgkin

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00398177
LYM0001 (Other Identifier)
IRB-13500 (Other Identifier)
76973 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Full description

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Enrollment

9,999 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
  • Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
  • A routine procedure for tissue collection is planned.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

  • Patients without NHL or Hodgkin's disease

Trial contacts and locations

1

Loading...

Central trial contact

Alyssa M Kanegai

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems